Investors

investor people image

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Osiris Cleared by FDA to Begin Stem Cell Trial for Knee Repair
The announcement marks the third adult stem cell product that Osiris has in human clinical trials.
View HTML
Toggle Summary Osiris Launches the First Trial Using Adult Universal Stem Cells in Cardiac Patients.
Landmark study focuses on promising therapy for the treatment of heart disease.
View HTML
Toggle Summary Osiris First to Announce FDA Fast Track Designation for a Stem Cell Product.
Decision seen as a positive sign for both Osiris and the emerging stem cell industry.
View HTML
Toggle Summary Osiris Therapeutics, Inc. Strengthens Executive Team.
Cary Claiborne named Chief Financial Officer. Harry Carmitchel named Chief Operating Officer.
View HTML
Toggle Summary Stem Cell Therapy Effectively Treats Heart Attacks in Animals
View HTML
Toggle Summary Researchers Turn To Adult Stem Cells View HTML
Toggle Summary Osiris Therapeutics appoints C. Randal Mills President and Chief Executive Officer
View HTML
Toggle Summary Osiris Therapeutics and JCR Pharmaceuticals Co., Ltd. announce Mesenchymal Stem Cell alliance for Japan
View HTML
Toggle Summary Boston Scientific and Osiris Therapeutics Announce Stem Cell Alliance: Alliance to develop and commercialize cardiovascular therapies using adult Mesenchymal Stem Cells View HTML